JACKSONVILLE, FL, March 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- mCig, Inc. (MCIG), an innovative biotech company focused on development and commercialization of over the counter, science-driven, botanical nutrigenetics targeting the endocannabinoid system, medical devices, and research & development, today announced a study by the American Society for Microbiology (publication dated June 23, 2019) that it found CBD is an active ingredient against Gram-positive Bacteria.
Dale Hipes, CEO of BareRoots Inc., the subsidiary of MCIG Inc., stated: “ We are very interested in the studies published demonstrating our efforts towards offering a botanical solution in a pharmaceutical world. We learned recently, the American Society for Microbiology found CBD is an active ingredient against Gram-positive Bacteria. The article goes on to say it is ‘active against those including serious infections such as Staphylococcus aureus and Streptococcus pneumonia.’ It is research that drives us in our efforts to continue our desire to educate our public that our tinctures (https://www.bareroots-rx.com/product-category/ingestibles/?filters=strength[clinical-strength-1000-mg]) offer properties that are valuable and may work in the effort to boost the immune system against such bacteria and viruses.”
Mr. Paul Rosenberg, CEO of MCIG, goes on to state, “It is the reason we chose BareRoots Rx as our joint venture partner to form BRRX Clinical Inc. Together, we are moving forward to offer our products in the best form to our customers as we live in a world enduring multiple challenges. The recent threats of the Coronavirus is of great concern for us all. We here at BRRX Clinical Inc. are offering special pricing to serve our public during these challenging times. We are sure the products we sell are available as a potential part of our solution in an emerging marketplace of CBD offering antiviral and anti gram bacterial solutions. Please feel free to visit our site (www.bareroots-rx.com) and use a coupon (BRRX30) for purchasing our products
Additionally we offer our new product BRRX.io which is a membership offering including labs and medical support through Telehealth and testing services. We have developed our products and our new app in love for our fellow mankind. All of our products are the highest grade organic, THC free, non GMO and glyphosate free. We are looking forward to serving you all.”
About MCIG Group
Headquartered in Jacksonville, Florida, mCig, Inc. (MCIG) is a diversified company servicing the legal cannabis, hemp and CBD markets via its lifestyle brands.
The Company has been featured in media nationwide, including CNBC, Bloomberg, TheStreet.com. For more information, visit www.mciggroup.com.
Visit us on Facebook @ https://www.facebook.com/mCigInc/
Follow us on Twitter @mcigInc
About BareRoots Rx Inc.
The company focused on the development and commercialization of OTC, science-driven, botanical nutrigenetics that target the endocannabinoid system. BareRoots Rx Inc. also delivers high-quality consumer and OTC THC-free CBD products that promote overall health and well being as well as state-of-the-art testing and analytics capabilities to our customers.
Forward-Looking Statements
This press release may include predictions, estimates or other information that might be considered forward-looking within the meaning of applicable securities laws. While these forward-looking statements represent the Company’s current judgments, they are subject to risks and uncertainties that could cause actual results to differ materially. You are cautioned not to place undue reliance on these forward-looking statements, which reflect the opinions of the Company’s management only as of the date of this release. Please keep in mind that the Company is not obligating itself to revise or publicly release the results of any revision to these forward-looking statements in light of new information or future events. When used herein, words such as: potential, expect, look forward, believe, dedicated, building, or variations of such words and similar expressions are intended to identify forward-looking statements. Factors that could cause actual results to differ materially from those contemplated in any forward-looking statements made by the Company herein are often discussed in filings the Company makes with the United States Securities and Exchange Commission (SEC) available at www.sec.gov and on the Company’s website at www.mciggroup.com.
Contact:
mCig, Inc.
Paul Rosenberg
paul@mciggroup.org